Company: AcelRx ($ACRX)Based: Redwood City, CARaised: $40M (8M shares at $5)Target range: $12 to $14Current price: $2.92
Scoop: AcelRx, which has a pipeline of post-operative and cancer pain drugs, initially shot for an $86 million IPO in 2010 bu…
Archive for the ‘AcelRx’ Category
AcelRx – Biotech IPOs of 2011
January 17th, 2012 
Maureen Martino 
Posted in AcelRx, Biotech IPO, Blog, Companies, Diagnostics, Funding, Medical Devices, Medical Supply, Pharmaceuticals, Startups, Universities, Videos 
Tags: biotech food social media 
Comments Off